Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph D Miller

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
American Journal of Public Health|July 2, 2026
COVID-19 Testing and Containment Strategies for Children in Congregate Housing Facilities in Texas, 2021-2023Andrew Godoshian, Zachary R Smith, Peter Boersma, et al.
MMWR. Morbidity and Mortality Weekly Report|February 1, 2024
Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, September 2023-January 2024Ruth Link-Gelles, Allison Avrich Ciesla, Josephine Mak, et al.
Journal of Psychosomatic Research|September 27, 2014
Change in consumption patterns for treatment-seeking patients with alcohol use disorder post-bariatric surgeryAlfredo B Cuellar-Barboza, Mark A Frye, Karen Grothe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2011
Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adultsJaikumar Duraiswamy, Chris C Ibegbu, David Masopust, et al.
MMWR. Morbidity and Mortality Weekly Report|December 1, 2022
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022Ruth Link-Gelles, Allison Avrich Ciesla, Katherine E Fleming-Dutra, et al.
Journal of Virological Methods|January 22, 2017
Evaluation of multiplex assay platforms for detection of influenza hemagglutinin subtype specific antibody responsesZhu-Nan Li, Kimberly M Weber, Rebecca A Limmer, et al.
MMWR. Morbidity and Mortality Weekly Report|February 16, 2023
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023Katherine E Fleming-Dutra, Allison Avrich Ciesla, Lauren E Roper, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 2009
The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell responseRama S Akondy, Nathan D Monson, Joseph D Miller, et al.
Influenza and Other Respiratory Viruses|February 17, 2017
Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applicationsZhu-Nan Li, Jessica F Trost, Kimberly M Weber, et al.
MMWR. Morbidity and Mortality Weekly Report|February 2, 2023
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023Ruth Link-Gelles, Allison Avrich Ciesla, Lauren E Roper, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
American Journal of Public Health|July 2, 2026
COVID-19 Testing and Containment Strategies for Children in Congregate Housing Facilities in Texas, 2021-2023Andrew Godoshian, Zachary R Smith, Peter Boersma, et al.
MMWR. Morbidity and Mortality Weekly Report|February 1, 2024
Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, September 2023-January 2024Ruth Link-Gelles, Allison Avrich Ciesla, Josephine Mak, et al.
Journal of Psychosomatic Research|September 27, 2014
Change in consumption patterns for treatment-seeking patients with alcohol use disorder post-bariatric surgeryAlfredo B Cuellar-Barboza, Mark A Frye, Karen Grothe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 9, 2011
Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adultsJaikumar Duraiswamy, Chris C Ibegbu, David Masopust, et al.
MMWR. Morbidity and Mortality Weekly Report|December 1, 2022
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022Ruth Link-Gelles, Allison Avrich Ciesla, Katherine E Fleming-Dutra, et al.
Journal of Virological Methods|January 22, 2017
Evaluation of multiplex assay platforms for detection of influenza hemagglutinin subtype specific antibody responsesZhu-Nan Li, Kimberly M Weber, Rebecca A Limmer, et al.
MMWR. Morbidity and Mortality Weekly Report|February 16, 2023
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023Katherine E Fleming-Dutra, Allison Avrich Ciesla, Lauren E Roper, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 26, 2009
The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell responseRama S Akondy, Nathan D Monson, Joseph D Miller, et al.
Influenza and Other Respiratory Viruses|February 17, 2017
Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applicationsZhu-Nan Li, Jessica F Trost, Kimberly M Weber, et al.
MMWR. Morbidity and Mortality Weekly Report|February 2, 2023
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023Ruth Link-Gelles, Allison Avrich Ciesla, Lauren E Roper, et al.
Pageof 7